Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Actinium Pharmaceuticals ( (ATNM) ) just unveiled an announcement.
Actinium Pharmaceuticals, Inc. held its 2024 annual stockholder meeting where Sandesh Seth and Jeffrey W. Chell were re-elected as Class II directors to serve until 2027. Additionally, Marcum LLP was ratified as the independent public accountant for the fiscal year 2024. The meeting saw the participation of 19,724,287 shares, with all proposals receiving approval from stockholders.
For a thorough assessment of ATNM stock, go to TipRanks’ Stock Analysis page.
